Navigation Links
Cardiovascular Technologies to be Highlighted at 5th Annual Cleveland Clinic Medical Innovation Summit, Oct. 1-3
Date:9/5/2007

CEOs, Venture Capitalists, Medical and Media Leaders Speakers and Panels;

Live Surgeries and 'Top 10' Innovations List to be Featured

CLEVELAND, Sept. 5 /PRNewswire/ -- Cleveland Clinic will host its annual Medical Innovation Summit, an international gathering of health care, business and media leaders to examine trends in medical innovation and cardiovascular technologies, Oct. 1-3.

The 2007 Medical Innovation Summit will feature:

-- Nationally Recognized Speakers and Panelists: Sidney Taurel, Eli

Lilly; George Buckley, 3M; Bill Hawkins, Medtronic; Stephen Hemsley,

UnitedHealth Group; Tony Zook, AstraZeneca; and many other CEOs, top

venture investors, medical leaders and network correspondents will

explore top technology issues in cardiovascular medicine including

drug-eluting stents, stem cells, personalized care, wellness,

implantable devices, and treating arrhythmias of the heart. A complete

list of speakers is available online at

http://www.clevelandclinic.org/innovations/summit/.

-- "Top 10" Health Care Innovations: Cleveland Clinic clinicians and

researchers will announce and discuss their second annual selection of

the "Top 10" medical innovations they expect to have a significant

impact in 2008.

-- Live Surgeries: Two live, interactive surgeries will illustrate state

of the art treatments for cardiovascular disease. Surgeries will be

broadcast in the Bank of America Conference Center of the

InterContinental Hotel Cleveland each morning at 7:30 a.m.

This marks the fifth year Cleveland Clinic has hosted this international gathering of industry decision-makers to dissect advances revolutionizing health care and accelerate the application of life-saving cardiovascular technologies. The 2007 Medical Innovation Summit will draw 900 industry executives, entrepreneurs, venture capitalists and clinicians. Also featured will be the Cleveland Clinic's annual selection of the "Top 10" health care innovations, live, interactive surgeries and in-depth debates on industry challenges.

For more information on the Medical Innovation Summit, including the agenda, please visit http://www.clevelandclinic.org/innovations/summit/.

CCF Innovations, the commercialization and innovation arm of Cleveland Clinic, organizes the Medical Innovation Summit, promotes innovation and is responsible for commercialization of all Cleveland Clinic technologies. CCF Innovations advances product-oriented innovation and transforms promising therapies, devices and diagnostics into beneficial medical products, via spin- off companies, licensees and equity partnerships.

Cleveland Clinic, located in Cleveland, Ohio, is a not-for-profit multispecialty academic medical center that integrates clinical and hospital care with research and education. Cleveland Clinic was founded in 1921 by four renowned physicians with a vision of providing outstanding patient care based upon the principles of cooperation, compassion and innovation. U.S. News & World Report consistently names Cleveland Clinic as one of the nation's best hospitals in its annual "America's Best Hospitals" survey. Approximately 1,800 full-time salaried physicians and researchers at Cleveland Clinic and Cleveland Clinic Florida represent more than 100 medical specialties and subspecialties. In 2006, there were 3.1 million outpatient visits to Cleveland Clinic. Patients came for treatment from every state and from more than 80 countries. There were more than 53,000 hospital admissions to Cleveland Clinic in 2006. Cleveland Clinic's Web site address is http://www.clevelandclinic.org.


'/>"/>
SOURCE Cleveland Clinic
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Abbott Laboratories to buy Biocompatibles cardiovascular stent business
2. High iron levels may cause Cardiovascular Disease in women
3. Air Pollution said To Increase Risk of Cardiovascular Disease
4. Link Between Alcohol Consumption And Cardiovascular Disease
5. Beer Found To Be Effective In Fighting Cardiovascular Disease
6. New Guidelines Found To Benefit Cardiovascular Treatment
7. Women With A High-Risk Of Cardiovascular Disease Under treated
8. People who fight wars may be at high risk of cardiovascular disease
9. Low glycemic diet effective for reducing cardiovascular risk
10. Air pollution to affect diabetes patients’ cardiovascular risks
11. Need for considering cardiovascular risks before giving HAART for HIV/aids patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... ... March 27, 2017 , ... ... CE Certificate of Conformity for the Smart System® 20/20. CE Certification builds upon ... industry standards and specifications such as ANSI, ISO and proven test methods used ...
(Date:3/27/2017)... ... March 27, 2017 , ... Osteitis pubis ... type of groin injury, it occurs when the muscles around the pelvis become ... and around the lower torso, as well as accompanying tenderness and weakness. Without ...
(Date:3/27/2017)... ... 2017 , ... EpiGentek , a Farmingdale, NY-based biotech ... methylation “gold rush” with their established portfolio of optimized assay kits that measure ... m6A , RNA methylation has received a new burst in interest as ...
(Date:3/27/2017)... ... , ... Janet Schloz is still in shock after receiving a $2,500 Academic Award from ... time,” she said. , She thinks the coming week is going to be a very ... have to help my students.” , The award will allow the 4th grade teacher at ...
(Date:3/27/2017)... ... March 27, 2017 , ... Sodium determination is consistently ... and require expert user knowledge. In a live webinar on April 11th and ... yet highly accurate, determination of sodium. , It has long been known that ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... BOSTON , March 27, 2017 /PRNewswire/ ... company and Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a ... of innovative therapies based upon tetracycline chemistry, announced ... for the treatment of moderate to severe acne ... is a once-daily, oral, narrow spectrum tetracycline-derived antibiotic ...
(Date:3/27/2017)... -- Impax Laboratories, Inc. (NASDAQ: IPXL)today announced that its Board ... as Impax,s President and Chief Executive Officer and a ... Mr. Bisaro will succeed J. Kevin Buchi , ... Officer since December of 2016. With ... Bisaro, 56, is an accomplished global business leader who ...
(Date:3/27/2017)... , March 27, 2017  PhaseRx, Inc. ... for life-threatening inherited liver diseases in children, today ... full year ended December 31, 2016 and provided ... "PhaseRx continued to make progress during the ... positive results from our non-human primate safety study, and ...
Breaking Medicine Technology: